Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · IEX Real-Time Price · USD

6.69

-0.17 (-2.48%)

At close: Apr 25, 2024, 4:00 PM

6.65

-0.04 (-0.60%)

After-hours: Apr 25, 2024, 4:39 PM EDT

Pulse Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-42.21	-58.51	-63.66	-49.85	-46.97	-37.55	-25.57	-9.52	-2.81
Depreciation & Amortization	1.21	1.36	1.15	1.1	1.16	1.31	1	0.76	0.72
Share-Based Compensation	7.18	5.19	14.6	10.08	11.29	12.34	10.93	0.87	0.4
Other Operating Activities	0.78	4.95	-6.18	3.32	0.34	0	2.55	-0.16	-1.63
Operating Cash Flow	-33.04	-47.01	-54.1	-35.37	-34.19	-23.9	-11.09	-8.05	-3.32
Capital Expenditures	-0.12	-0.4	-0.44	-0.44	-0.61	-0.28	-2.55	-0.06	-0.09
Change in Investments	0	0	8	10.49	-9.49	26.39	-20.45	-14.32	0
Investing Cash Flow	-0.12	-0.4	7.56	10.04	-10.1	26.12	-23	-14.38	-0.09
Share Issuance / Repurchase	16.39	15.38	62.51	30.89	0.7	45.61	35.38	20.92	0
Debt Issued / Paid	-0.01	64.56	0.41	0	0	0	0	0	0
Other Financing Activities	-	-	-0.23	-	-0.61	-0.12	-	-	-
Financing Cash Flow	16.39	79.94	62.69	30.89	0.08	45.5	35.38	20.92	0
Net Cash Flow	-16.77	32.53	16.15	5.56	-44.2	47.72	1.3	-1.52	-3.4
Free Cash Flow	-33.16	-47.41	-54.53	-35.81	-34.79	-24.17	-13.64	-8.12	-3.4
Free Cash Flow Margin	-	-6773.43%	-3845.84%	-	-	-	-	-	-
Free Cash Flow Per Share	-0.69	-1.40	-1.95	-1.54	-1.68	-1.42	-0.92	-0.74	-0.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).